SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 3,358.43 |
| Enterprise Value ($M) | 2,885.49 |
| Book Value ($M) | 449.05 |
| Book Value / Share | 3.06 |
| Price / Book | 7.48 |
| NCAV ($M) | 440.72 |
| NCAV / Share | 3.00 |
| Price / NCAV | 7.62 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.72 |
| Return on Assets (ROA) | -0.45 |
| Return on Equity (ROE) | -0.48 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.61 |
| Current Ratio | 7.61 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 507.37 |
| Assets | 515.71 |
| Liabilities | 66.65 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Non Redeemable Common Stock Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Fmr Llc | 8.56 | 59.19 | |
| 13G/A | Deep Track Capital, LP | 0.69 | -89.70 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 338,853 | 1,095,062 | 30.94 | |
| 312,986 | 1,225,257 | 25.54 | |
| 166,190 | 935,565 | 17.76 | |
| 176,972 | 633,905 | 27.92 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IFRX – InflaRx N.V. | IGMS – IGM Biosciences, Inc. |
| IMUX – Immunic, Inc. | INBX – Inhibrx Biosciences, Inc. |
| INDV – Indivior PLC |
Financial data and stock pages provided by
Fintel.io